Dow Up 0.04% Nasdaq Up 0.89%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
54.08 Up 1.03(1.94%) 4:00PM EST
|After Hours : 54.09 Up 0.01 (0.01%) 5:11PM EST
Prev Close:53.05
Open:53.21
Bid:53.95 x 100
Ask:58.01 x 100
1y Target Est:87.50
Beta:2.04
Earnings Date:Feb 9 - Feb 13 (Est.)
Day's Range:53.03 - 54.45
52wk Range:41.99 - 80.42
Volume:241,700
Avg Vol (3m):390,352
Market Cap:1.08B
P/E (ttm):163.88
EPS (ttm):0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
LGNDUp 1.94%1.08B
LLYDown 0.64%71.59B
MRKDown 0.69%168.91B
RHHBYUp 0.05%253.79B

Key Statistics

Forward P/E (1 yr):23.11
P/S (ttm):18.88
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.53
Quarterly EPS Est (Dec-14) :0.61
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.17

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback